Related Experiment Videos

[Integrins, cell response to anti-tumor agents and chemoresistance]

Sylvie Maubant1, Cathy Staedel, Pascal Gauduchon

  • 1Groupe régional d'études sur le cancer, EA 1772 de l'université de Caen, Laboratoire de cancérologie expérimentale, Centre de lutte contre le cancer François-Baclesse, route de Lion-sur-Mer, 14076 Caen Cedex 05, France.

Bulletin Du Cancer
|December 24, 2002
PubMed

Insights

Integrins, crucial for cell adhesion and tumor growth, can affect anti-cancer drug effectiveness. Understanding integrin roles in chemoresistance may improve cancer therapy.

Area of Science:

  • Cellular Biology
  • Molecular Oncology
  • Biochemistry

Context:

  • Integrins are transmembrane receptors mediating cell adhesion, vital for cellular functions like proliferation and survival.
  • Integrin signaling plays a key role in tumor development and progression.
  • In vitro studies suggest integrin ligation influences anti-tumor agent cytotoxicity.

Purpose:

  • To explore the role of integrins in modulating anti-tumor agent efficacy.
  • To investigate the molecular mechanisms linking integrin signaling to cell cycle and apoptosis pathways.
  • To examine the involvement of integrins in the development of chemoresistance.

Summary:

  • Integrin ligation by extracellular matrix proteins can alter anti-tumor agent cytotoxicity in a cell-type specific manner.
  • The molecular basis for this modulation may involve interactions between integrin signaling and cell cycle/apoptosis pathways.
  • Altered integrin expression or function is observed in cells developing chemoresistance after chronic exposure to cytotoxic agents.

Impact:

  • Integrins are implicated in chemoresistance mechanisms.
  • Findings suggest integrins as potential therapeutic targets in cancer treatment.
  • This research opens new avenues for cancer therapy and prognosis.

Related Concept Videos